.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Rufinamide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for rufinamide?

Rufinamide is the generic ingredient in two branded drugs marketed by Eisai Inc, Glenmark Pharms Ltd, West-ward Pharms Int, and Mylan Pharms Inc, and is included in five NDAs. There are four patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for rufinamide. One supplier is listed for this compound.

Summary for Generic Name: rufinamide

Tradenames:2
Patents:4
Applicants:4
NDAs:5
Drug Master File Entries: see list6
Suppliers / Packagers: see list1
Bulk Api Vendors: see list67
Clinical Trials: see list8
Patent Applications: see list473
Drug Prices:see low prices
DailyMed Link:rufinamide at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eisai Inc
BANZEL
rufinamide
TABLET;ORAL021911-002Nov 14, 2008RXYesNo8,076,362*PED► SubscribeY► Subscribe
Eisai Inc
BANZEL
rufinamide
TABLET;ORAL021911-001Nov 14, 2008DISCNYesNo8,076,362*PED► SubscribeY► Subscribe
Eisai Inc
BANZEL
rufinamide
TABLET;ORAL021911-001Nov 14, 2008DISCNYesNo7,750,028*PED► SubscribeY► Subscribe
Eisai Inc
BANZEL
rufinamide
TABLET;ORAL021911-002Nov 14, 2008RXYesNo7,750,028*PED► SubscribeY► Subscribe
Eisai Inc
BANZEL
rufinamide
TABLET;ORAL021911-003Nov 14, 2008RXYesYes7,750,028*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc